WallStreetZenWallStreetZen

NASDAQ: DCTH
Delcath Systems Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for DCTH

Based on 2 analysts offering 12 month price targets for Delcath Systems Inc.
Min Forecast
$19.00+481.04%
Avg Forecast
$19.50+496.33%
Max Forecast
$20.00+511.62%

Should I buy or sell DCTH stock?

Based on 2 analysts offering ratings for Delcath Systems Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DCTH stock forecasts and price targets.

DCTH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 7%
7
BuyMaintains$19.00+481.04%2022-08-10
BTIG
Top 8%
93
Strong BuyMaintains$20.00+511.62%2022-06-24

1 of 1

Forecast return on equity

Is DCTH forecast to generate an efficient return?
Company
0%
Industry
24.32%
Market
118.57%
DCTH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DCTH forecast to generate an efficient return on assets?
Company
0%
Industry
13.22%
DCTH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DCTH earnings per share forecast

What is DCTH's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$3.86
Avg 2 year Forecast
-$1.89
Avg 3 year Forecast
-$0.92

DCTH revenue forecast

What is DCTH's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$2.9M-24.84%
Avg 2 year Forecast
$17.4M+356.5%
Avg 3 year Forecast
$43.2M+1,036.53%
DCTH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DCTH revenue growth forecast

How is DCTH forecast to perform vs Medical Devices companies and vs the US market?
Company
121.5%
Industry
4.76%
Market
8.46%
DCTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DCTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DCTH vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
DCTH$3.27$19.50+496.33%Strong Buy
VERO$0.43$5.50+1,191.08%Strong Buy
SSKN$0.84$4.30+411.90%Strong Buy
NMTC$1.89N/AN/AHold
SONX$1.18$12.58+966.10%Strong Buy

Delcath Systems Stock Forecast FAQ

Is Delcath Systems Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: DCTH) stock is to Strong Buy DCTH stock.

Out of 2 analysts, 1 (50%) are recommending DCTH as a Strong Buy, 1 (50%) are recommending DCTH as a Buy, 0 (0%) are recommending DCTH as a Hold, 0 (0%) are recommending DCTH as a Sell, and 0 (0%) are recommending DCTH as a Strong Sell.

If you're new to stock investing, here's how to buy Delcath Systems stock.

What is DCTH's earnings growth forecast for 2022-2024?

(NASDAQ: DCTH) Delcath Systems's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 19.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.42%.

Delcath Systems's earnings in 2022 is -$30,332,000.On average, 2 Wall Street analysts forecast DCTH's earnings for 2022 to be -$33,187,053, with the lowest DCTH earnings forecast at -$33,702,913, and the highest DCTH earnings forecast at -$32,671,192. On average, 2 Wall Street analysts forecast DCTH's earnings for 2023 to be -$16,249,619, with the lowest DCTH earnings forecast at -$18,656,970, and the highest DCTH earnings forecast at -$13,756,291.

In 2024, DCTH is forecast to generate -$7,909,867 in earnings, with the lowest earnings forecast at -$17,109,387 and the highest earnings forecast at $1,289,652.

What is DCTH's revenue growth forecast for 2022-2024?

(NASDAQ: DCTH) Delcath Systems's forecast annual revenue growth rate of 121.5% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 4.76%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.46%.

Delcath Systems's revenue in 2022 is $3,805,000.On average, 2 Wall Street analysts forecast DCTH's revenue for 2022 to be $24,589,371, with the lowest DCTH revenue forecast at $24,331,440, and the highest DCTH revenue forecast at $24,847,301. On average, 2 Wall Street analysts forecast DCTH's revenue for 2023 to be $149,341,736, with the lowest DCTH revenue forecast at $86,148,774, and the highest DCTH revenue forecast at $212,534,699.

In 2024, DCTH is forecast to generate $371,806,758 in revenue, with the lowest revenue forecast at $187,773,375 and the highest revenue forecast at $555,840,141.

What is DCTH's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: DCTH) forecast ROA is 0%, which is lower than the forecast US Medical Devices industry average of 13.22%.

What is DCTH's Price Target?

According to 2 Wall Street analysts that have issued a 1 year DCTH price target, the average DCTH price target is $19.50, with the highest DCTH stock price forecast at $20.00 and the lowest DCTH stock price forecast at $19.00.

On average, Wall Street analysts predict that Delcath Systems's share price could reach $19.50 by Aug 10, 2023. The average Delcath Systems stock price prediction forecasts a potential upside of 496.33% from the current DCTH share price of $3.27.

What is DCTH's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: DCTH) Delcath Systems's current Earnings Per Share (EPS) is -$3.78. On average, analysts forecast that DCTH's EPS will be -$3.86 for 2022, with the lowest EPS forecast at -$3.92, and the highest EPS forecast at -$3.80. On average, analysts forecast that DCTH's EPS will be -$1.89 for 2023, with the lowest EPS forecast at -$2.17, and the highest EPS forecast at -$1.60. In 2024, DCTH's EPS is forecast to hit -$0.92 (min: -$1.99, max: $0.15).

What is DCTH's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: DCTH) forecast ROE is 0%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.